Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022
Harrow (Nasdaq: HROW) will announce its third-quarter financial results for the period ending September 30, 2022, on November 14, 2022, after market close. A conference call will follow at 4:45 p.m. Eastern Time to discuss the results and company updates. Investors can access related materials through Harrow's website. The company is dedicated to developing innovative, affordable ophthalmic therapies.
- Focus on developing innovative ophthalmic therapies may drive future growth.
- None.
Conference Call Details: |
|
Date: |
|
Time: |
|
|
1-833-953-2434 ( |
(telephonic replay through |
1-877-344-7529 ( |
Webcast: (online replay through |
About Harrow
Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/
jwebb@harrowinc.com
615-733-4737
Source: Harrow
FAQ
When will Harrow release its Q3 financial results?
What time is Harrow's conference call on November 14, 2022?
Where can I find Harrow's third quarter Letter to Stockholders?